ARTICLE | Clinical News
IL13-PE38 fusion protein regulatory update
December 3, 2001 8:00 AM UTC
The FDA granted Orphan Drug designation to NEOL's IL13-PE38 fusion protein of IL-13 with a Pseudomonas exotoxin, which is in Phase I/II testing to treat malignant glioma. ...